Ovid Therapeutics OVID
NASDAQ OVID
$2.38 -0.05 (-2.06%)
At close: Oct 2, 2026 · 4:00 PM EDT

Ovid Therapeutics (OVID) Shares Outstanding (Diluted) (2020 - 2026)

Updated

Ovid Therapeutics (OVID) recorded Shares Outstanding (Diluted) of 197.45 million in Q2 2026, up 177.7% from 71.11 million a year earlier and up 45.0% from the prior quarter.

Analysis

Ovid Therapeutics (OVID) Shares Outstanding (Diluted) (2020 - 2026) Analysis & Trends

For FY2025, Ovid Therapeutics reported Shares Outstanding (Diluted) of 73.74 million, up 4.0% from FY2024.

  • Annual Shares Outstanding (Diluted) has increased for five straight years, with a five-year compound annual growth rate of 4.8% (FY2020 to FY2025).
  • Across earlier years, Shares Outstanding (Diluted) came in at 70.91 million in FY2024 (+0.5%), 70.58 million in FY2023 (+0.2%), 70.42 million in FY2022 (+3.5%) and 68.07 million in FY2021 (+16.5%).
  • The Q2 2026 figure is the highest quarterly Shares Outstanding (Diluted) in data going back to Q1 2020.
  • On a year-over-year basis, Shares Outstanding (Diluted) has increased for four consecutive quarters, with growth averaging 34.4% over the last eight quarters.
  • Peak year-over-year performance for Shares Outstanding (Diluted) in the last five years was growth of 177.7% in Q2 2026, against a decline of 0.1% in Q2 2025 at the low end.
  • Per Business Quant, the preceding three quarters came in at 136.17 million (Q1 2026), 73.74 million (Q4 2025) and 71.11 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Dil.) (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn 893.70 Mn
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn 2.44 Bn
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn 1.77 Bn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn 2.47 Bn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn 1.96 Bn
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn 1.56 Bn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn 544.00 Mn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn 1.24 Bn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn 5.70 Bn
10 Ovid Therapeutics 448.96 Mn 80.98 Mn - 197.45 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 197.45 Mn
Mar 31, 2026 136.17 Mn
Dec 31, 2025 73.74 Mn
Sep 30, 2025 71.11 Mn
Jun 30, 2025 71.11 Mn
Mar 31, 2025 71.05 Mn
Dec 31, 2024 70.91 Mn
Sep 30, 2024 70.98 Mn
Jun 30, 2024 71.20 Mn
Mar 31, 2024 70.72 Mn
Dec 31, 2023 70.58 Mn
Sep 30, 2023 70.62 Mn
Jun 30, 2023 70.53 Mn
Mar 31, 2023 70.49 Mn
Dec 31, 2022 70.42 Mn
Sep 30, 2022 70.43 Mn
Jun 30, 2022 70.39 Mn
Mar 31, 2022 70.35 Mn
Dec 31, 2021 68.07 Mn
Sep 30, 2021 67.93 Mn
API Access

Ovid Therapeutics Shares Outstanding (Diluted) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=OVID&period=max&api_key=YOUR_API_KEY